West Pharmaceutical Services Inc. has expanded capabilities at its Scottsdale, Ariz., facility to meet increased customer demand for the SmartDose Electronic Wearable Injector. The expansion in Scottsdale will enable continuing development and production of SmartDose to accommodate rising interest in the product.
“Expanding our manufacturing capabilities in Scottsdale – and continuing scaling up production in Israel – will enable rapid, dual sourcing to our customers and help them bring innovative new treatments to market,” said Eric Resnick, president, Pharmaceutical Delivery Systems, Proprietary Products at West. “Medication adherence is an ongoing challenge in the pharmaceutical industry, and non-adherence is a leading cause of poor clinical outcomes and increased healthcare costs.”
West says with the treatment of many chronic illnesses shifting out of clinical settings to home care and self-administration, there is growing need for drug products that can be easily injected by patients. Designed to deliver high volumes of injectable drugs over an extended period of time, SmartDose makes it easier for patients to self-administer medication and encourages compliance with prescribed treatments.
The expanded capabilities at the Scottsdale site include clean room manufacturing and additional laboratory space. New jobs are being created in R&D, engineering, quality and operations functions to ramp-up production, new development and sustainment engineering.